U.S. markets close in 1 hour 22 minutes
  • S&P 500

    3,859.05
    -66.38 (-1.69%)
     
  • Dow 30

    31,602.08
    -359.78 (-1.13%)
     
  • Nasdaq

    13,275.96
    -322.01 (-2.37%)
     
  • Russell 2000

    2,244.10
    -40.28 (-1.76%)
     
  • Crude Oil

    63.58
    +0.36 (+0.57%)
     
  • Gold

    1,773.90
    -24.00 (-1.33%)
     
  • Silver

    27.58
    -0.35 (-1.25%)
     
  • EUR/USD

    1.2189
    +0.0021 (+0.17%)
     
  • 10-Yr Bond

    1.4800
    +0.0910 (+6.55%)
     
  • GBP/USD

    1.4043
    -0.0098 (-0.70%)
     
  • USD/JPY

    106.1820
    +0.3000 (+0.28%)
     
  • BTC-USD

    49,740.59
    -149.91 (-0.30%)
     
  • CMC Crypto 200

    995.40
    +0.74 (+0.07%)
     
  • FTSE 100

    6,651.96
    -7.01 (-0.11%)
     
  • Nikkei 225

    30,168.27
    +496.57 (+1.67%)
     

Clovis: 4Q Earnings Snapshot

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

BOULDER, Colo. (AP) _ Clovis Oncology Inc. (CLVS) on Tuesday reported a loss of $99 million in its fourth quarter.

The Boulder, Colorado-based company said it had a loss of $1.02 per share. Losses, adjusted for non-recurring costs, came to 74 cents per share.

The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 76 cents per share.

The biopharmaceutical company posted revenue of $43.3 million in the period, which also beat Street forecasts. Four analysts surveyed by Zacks expected $43.2 million.

For the year, the company reported that its loss narrowed to $369.2 million, or $4.38 per share. Revenue was reported as $164.5 million.

Clovis shares have risen 39% since the beginning of the year. The stock has declined 38% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CLVS at https://www.zacks.com/ap/CLVS